These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1872098)

  • 1. [The immunochemistry of the antigenic fractions of Clostridium tetani toxin].
    Vaĭsman ISh; Postanogova GV
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Mar; (3):54-7. PubMed ID: 1872098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antigen localization at the ultrastructural level in Clostridium tetani].
    Vaĭsman ISh; Postanogova GV; Chemurzieva NV
    Izv Akad Nauk SSSR Biol; 1987; (4):596-606. PubMed ID: 3312353
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative immunochemical study of the antigenic makeup of native tetanus toxin from sporulating and nonsporulating C1. tetani strains].
    Volgin IuB; Réthy L; Ráskai M
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jun; (6):47-51. PubMed ID: 821277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extraction of a specific ferroglobulin for tetanospasmin and an electron microscopic study of the process of toxinogenesis in Cl. tetani].
    Volgin IuB; Pavlova IB; Shakhanina KL
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Feb; (2):79-83. PubMed ID: 4616572
    [No Abstract]   [Full Text] [Related]  

  • 5. [The isolation of tetanolysin and study of its protective activity].
    Postanogova GV; Efimova NP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Feb; (2):48-51. PubMed ID: 1867035
    [No Abstract]   [Full Text] [Related]  

  • 6. Current concepts in the management of Clostridium tetani infection.
    Brook I
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):327-36. PubMed ID: 18588497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Production of tetanolysin preparations and characteristics of their properties].
    Shabarov IA; Rumiantsev SN; Pospelov VF
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jun; (6):3-6. PubMed ID: 3898671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of monoplex assays detecting antibodies against Corynebacterium diphtheriae and Clostridium tetani toxins, rubella virus and parvovirus B19 for incorporation into Multiplex Serology.
    Brenner N; Butt J; Bomfim IL; Tabatabai J; Pawlita M; Schnitzler P; Waterboer T
    Methods; 2019 Apr; 158():44-53. PubMed ID: 30703462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunoenzimatic detection of the Clostridium tetani bacterial toxin: an alternative to mice bioassays].
    Chaves F; León G; Hernández-Chavarría F
    Rev Biol Trop; 2006 Jun; 54(2):253-6. PubMed ID: 18494295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and construction of immune phage antibody library against Tetanus neurotoxin: Production of single chain antibody fragments.
    Sadreddini S; Seifi-Najmi M; Ghasemi B; Kafil HS; Alinejad V; Sadreddini S; Younesi V; Jadidi-Niaragh F; Yousefi M
    Hum Antibodies; 2015 Dec; 23(3-4):73-9. PubMed ID: 27472865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against Staphylococcus aureus and tetanus infections by a combined vaccine containing SasA and TeNT‑Hc in mice.
    Yang Y; Yu R; Yang X; Liu S; Fang T; Song X; Hou L; Yu C; Xu J; Fu L; Yi S; Chen W
    Mol Med Rep; 2017 Apr; 15(4):2369-2373. PubMed ID: 28259925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-phase radioimmunoassay in antibody-coated tubes for the quantitative determination of tetanus antibodies.
    Bernáth S; Habermann E
    Med Microbiol Immunol; 1974; 160(1):47-51. PubMed ID: 4607818
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular Methods for Identification of Clostridium tetani by Targeting Neurotoxin.
    Nagoba B; Dharne M; Gohil KN
    Methods Mol Biol; 2017; 1600():37-47. PubMed ID: 28478555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of neutralizing monoclonal antibodies directed against tetanus toxin fragment C.
    Yousefi M; Tahmasebi F; Younesi V; Razavi A; Khoshnoodi J; Bayat AA; Abbasi E; Rabbani H; Jeddi-Tehrani M; Shokri F
    J Immunotoxicol; 2014; 11(1):28-34. PubMed ID: 23369087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The immunogenic and antigenic properties of the individual fractions of tetanus anatoxin].
    Runova VF; Kargina TM; Selezneva VP
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):75-6. PubMed ID: 7879554
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccination against diphtheria and tetanus. Assays, antigens, adjuvants and application.
    Aggerbeck H
    APMIS Suppl; 1998; 81():1-40. PubMed ID: 9810281
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolation and some properties of nontoxigenic derivatives of a strain of Clostridium tetani.
    Hara T; Matsuda M; Yoneda M
    Biken J; 1977 Dec; 20(3-4):105-15. PubMed ID: 352338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of purified tetanus toxin and toxoid.
    Raynaud M; Turpin A; Bizzini B
    Prog Immunobiol Stand; 1967; 3():244-7. PubMed ID: 4985511
    [No Abstract]   [Full Text] [Related]  

  • 19. [Characteristics of the immune response of inoculated and intact animals to the administration of toxigenic and nontoxigenic strains of Clostridium tetani].
    Shvarts SA; Stovbun SF; Bukova VE; Anisimova LA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):82-6. PubMed ID: 3518309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization against Clostridium perfringens cells elicits protection against Clostridium tetani in mouse model: identification of cross-reactive proteins using proteomic methodologies.
    Alam SI; Bansod S; Singh L
    BMC Microbiol; 2008 Nov; 8():194. PubMed ID: 19000325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.